BNOEF

Bionomics Ltd.

 
Ordinary Shares International Reporting
OTCQX International OTCQX Advisor: Cowen and Company, LLC
Verified Company Profile 12/05/2016
Contact Info
  • 31 Dalgleish Street
  • Thebarton, SA 5031
  • Australia

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Sep 30, 2016 Quarterly Report
CIK 0001194833
Fiscal Year End 6/30
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: South Australia, Australia
Year of Inc. 1996
Employees 64 a/o Jun 30, 2014
Company Officers/Contacts
Deborah Rathjen CEO
Melanie Young CFO
Jack Moschakis Legal Counsel, Company Secretary Manager
Company Directors
Errol De Souza Chairman
Alan Fisher
Deborah Rathjen
Peter Turner
David Wilson
Service Providers
OTCQX Advisor
Cowen and Company, LLC
599 Lexington Avenue
New York, NY, 10019
USA

Accounting/Auditing Firm
Deloitte Touche Tohmatsu
Woodside Plaza Level 14
240 St Georges Tce
Perth, WA, 6000
Australia

Legal Counsel
Johnson Winter & Slattery
Level 9
211 Victoria Square
Adelaide, SA, 5000
Australia

Investor Relations Firm
Stern IR, Inc.
19 West 87th Street
Suite 400
New York, NY, 5000
United States

BNOEF Security Details
Share Structure
Market Value1 $133,287,538 a/o Dec 07, 2016
Authorized Shares 481,182,446 a/o Oct 05, 2016
Outstanding Shares 481,182,446 a/o Oct 05, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
BNO - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
Oct 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security